Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

KalVista Pharmaceuticals, Inc.

KALV

Valuace

Růst

Zdraví

Cena

$ 20.31

-0.36 (-2.41%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Revenues	75.0	0.0	0.0	0.0	0.0	12.7	12.7	16.1	8.4	1.5	2.1	1.8	0.4	1.5
Cost of Revenues	23.5	0.0	86.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	51.6	0.0	-86.2	-0.8	0.0	12.7	12.7	16.1	8.4	1.5	2.1	1.8	0.4	1.5

Revenue	3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Total Revenues	59.9	13.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	5.8	1.2	0.6	15.9	0.0	0.0	0.0	25.2	0.2	19.1
Gross Profit	54.1	12.5	0.8	-15.9	0.0	0.0	0.0	-25.2	-0.2	-19.1

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
R&D Expenses	0.0	0.0	0.0	80.3	70.2	41.3	40.2	35.0	18.2	12.7	14.7	8.3	4.2	2.0
Selling General & Admin Expenses	0.0	0.0	0.0	30.6	26.4	16.6	13.0	10.9	8.9	11.2	2.7	1.6	1.4	1.4
Depreciation & Amortization	1.5	0.9	0.8	0.8	2.1	-0.3	0.9	0.4	0.2	0.0	0.0	0.0	0.0	0.0
Total Operating Expenses	225.0	188.0	54.3	110.9	96.6	57.9	53.2	45.9	27.1	23.8	17.3	9.9	5.6	3.4
Operating Income	-173.4	-188.0	-140.4	-110.9	-96.6	-57.9	-40.5	-29.8	-18.7	-22.3	-15.2	-8.1	-5.2	-1.8

Operating Income	TTM	3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation & Amortization	0.6	0.4	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2
Total Operating Expenses	67.5	58.5	59.8	39.1	42.9	45.8	44.2	23.2	32.9	10.7
Operating Income	-13.3	-46.1	-59.0	-55.0	-42.9	-45.8	-44.2	-48.5	-33.2	-29.7

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Interest Income	9.1	6.4	0.0	2.2	1.1	0.9	1.8	1.4	0.1	0.0	0.1	0.0	0.0	0.0
Interest Expense	19.9	5.8	0.0	0.0	1.1	0.0	0.0	-9.2	-2.9	-3.7	-3.7	-0.9	0.4	0.3
Other Expense	2.6	7.9	5.3	18.0	14.3	11.7	11.3	7.7	2.8	3.7	3.7	0.8	-0.1	0.0
IBT	-170.8	-180.1	-135.1	-92.9	-82.3	-46.2	-29.2	-20.7	-15.8	-18.6	-11.4	-7.2	-5.7	-2.1
Income Tax Expense	-3.6	3.4	-8.5	-18.1	-13.8	-1.8	-0.1	0.1	-1.3	-5.1	-5.4	-0.9	0.5	0.2
Net Income	-167.2	-183.4	-126.6	-74.9	-68.5	-44.5	-29.1	-20.8	-15.8	-18.6	-11.4	-7.2	-5.7	-2.1

Net Income	TTM	3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Interest Income	3.4	1.9	1.8	2.0	1.4	1.4	1.7	1.5	0.7	0.8
Interest Expense	8.6	4.8	3.5	2.9	2.8	0.0	0.0	0.0	0.0	0.0
Other Expense	0.8	-1.3	1.1	1.9	-1.3	3.5	3.8	3.8	4.1	2.1
IBT	-12.5	-47.3	-57.9	-53.1	-44.3	-42.3	-40.4	-44.6	-29.0	-27.7
Income Tax Expense	-7.1	2.2	2.2	-0.9	4.2	0.0	0.0	0.0	0.0	0.0
Net Income	-5.4	-49.5	-60.1	-52.2	-48.5	-42.3	-40.4	-44.6	-29.0	-27.7

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
EPS	$0.00	$0.00	$0.00	$-2.68	$-2.80	$-2.33	$-1.64	$-1.38	$-1.53	$-4.00	$-19.34	$-27.44	$-7.83	$-2.83
EPS Diluted	$0.00	$0.00	$0.00	$-2.68	$-2.80	$-2.33	$-1.64	$-1.38	$-1.53	$-4.00	$-19.34	$-27.44	$-7.83	$-2.83
Shares Outstanding	50.5	49.7	36.8	27.9	24.5	19.1	17.7	15.1	10.3	4.6	0.6	0.3	0.7	0.7
Diluted Shares Outstanding	50.5	49.7	36.8	27.9	24.5	19.1	17.7	15.1	10.3	4.6	0.6	0.3	0.7	0.7

Per Share Data	TTM	3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Shares Outstanding	50.5	53.9	53.5	49.7	52.6	46.7	46.2	43.6	34.7	34.6
Diluted Shares Outstanding	50.5	53.9	53.5	49.7	52.6	46.7	46.2	43.6	34.7	34.6

Current Assets	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash And Equivalents	31.8	98.6	31.8	56.2	30.7	50.6	15.8	32.0	51.1	31.0	21.8	3.9	9.8	8.2
Short Term Investments	178.6	89.0	178.6	93.1	135.5	198.3	51.9	68.8	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments	210.4	187.6	210.4	149.4	166.2	248.9	67.7	100.8	51.1	31.0	21.8	3.9	9.8	8.2
Accounts Receivable	10.9	15.1	10.9	16.6	14.1	10.4	16.5	11.3	6.8	2.5	2.2	0.0	0.0	0.0
Inventory	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	4.4	38.9	4.4	4.3	10.6	4.9	4.5	0.0	1.5	0.8	0.7	0.7	0.1	0.1
Total Current Assets	225.7	241.7	225.7	172.3	193.6	264.3	88.7	115.5	59.4	34.2	24.7	4.6	9.9	8.3

Current Assets	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Cash And Equivalents	243.5	124.3	98.6	167.3	41.6	31.8	31.8	23.1	57.7	49.4
Short Term Investments	65.7	67.2	89.0	85.9	94.2	142.4	178.6	52.5	45.5	73.8
Total Cash & ST Investments	309.2	191.5	187.6	253.2	135.8	174.3	210.4	75.6	103.2	123.3
Accounts Receivable	7.1	6.5	15.1	9.4	0.0	12.3	10.9	23.7	0.0	0.0
Inventory	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	8.5	7.9	38.9	4.8	16.5	5.1	4.4	4.8	25.4	26.6
Total Current Assets	325.2	205.9	241.7	267.4	152.3	191.6	225.7	104.1	128.6	149.8

Long-Term Assets	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Property, Plant & Equipment	9.1	2.0	9.1	10.8	10.0	7.5	3.7	2.4	1.8	0.1	0.1	0.2	0.1	0.1
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	0.6	7.1	0.6	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.1	0.1
Total Long-Term Assets	9.7	9.1	9.7	10.9	10.2	7.7	3.8	2.6	2.0	0.1	0.1	2.1	0.2	0.2
Total Assets	235.4	250.8	235.4	183.2	203.9	272.0	92.5	118.1	61.4	34.3	24.7	6.6	10.1	8.5

Long-Term Assets	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Net Property, Plant & Equipment	12.3	7.2	2.0	7.2	7.9	8.0	9.1	9.5	9.8	10.4
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	2.4	2.4	7.1	1.4	0.7	0.6	0.6	0.4	0.3	0.1
Total Long-Term Assets	14.7	9.6	9.1	8.6	8.6	8.6	9.7	9.9	10.1	10.5
Total Assets	339.9	215.5	250.8	276.0	160.8	200.2	235.4	114.0	138.7	160.3

Current Liabilities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Accounts Payable	9.1	4.9	9.1	4.8	3.6	2.0	1.7	2.9	1.4	1.2	1.0	1.0	0.5	0.1
Short-Term Debt	1.3	2.0	1.3	1.1	1.0	0.9	0.6	0.1	0.2	0.0	0.0	4.4	3.1	2.7
Other Current Liabilities	12.4	27.3	12.4	9.1	7.0	6.9	5.5	5.6	3.1	1.9	2.2	1.6	0.4	0.2
Current Liabilities	22.8	45.2	22.8	15.0	11.6	9.8	7.7	18.1	23.2	3.0	3.2	7.1	4.0	3.1

Current Liabilities	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Accounts Payable	8.1	5.9	4.9	5.9	5.2	10.8	9.1	3.1	4.9	5.1
Short-Term Debt	1.4	2.1	2.0	1.4	1.5	1.3	1.3	1.2	1.1	1.1
Other Current Liabilities	24.1	19.0	27.3	18.3	15.4	10.4	12.4	14.8	11.7	8.0
Current Liabilities	45.1	38.4	45.2	25.6	22.2	22.4	22.8	19.1	17.8	14.1

Long-Term Liabilities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Long-Term Debt	6.0	4.3	6.0	7.1	7.2	5.0	1.1	0.0	0.1	0.0	0.0	2.1	0.0	0.0
Capital Leases	6.0	6.3	7.3	8.2	8.2	5.9	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0
Total Liabilities	28.8	155.4	28.8	22.2	18.8	14.8	8.8	21.4	34.1	3.0	3.2	50.8	43.8	36.8

Long-Term Liabilities	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Long-Term Debt	148.2	4.0	4.3	4.3	4.7	5.0	6.0	6.3	6.5	6.9
Capital Leases	10.6	6.1	6.3	5.8	6.2	6.3	6.0	7.4	7.7	8.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	322.9	174.7	155.4	130.9	26.8	27.4	28.8	25.4	24.3	21.0

Total Common Equity	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Common Stock	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-469.7	-653.2	-469.7	-343.1	-250.2	-167.8	-121.6	-92.5	-71.7	-55.9	-37.3	-47.8	-34.4	-28.7
Comprehensive Income	-3.5	-5.2	-3.5	-3.1	-3.9	-1.4	-1.9	-1.9	-1.1	-2.6	-0.1	-0.5	-0.4	-0.4
Total Common Equity	206.6	95.4	206.6	161.0	185.1	257.2	83.8	96.7	27.3	31.3	21.5	-44.2	-33.7	-28.3

Total Common Equity	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Common Stock	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-739.1	-713.3	-653.2	-600.9	-552.4	-510.2	-469.7	-425.1	-396.0	-368.4
Comprehensive Income	-6.7	-6.4	-5.2	-2.2	-2.7	-2.9	-3.5	-3.3	-3.5	-2.9
Total Common Equity	17.0	40.8	95.4	145.1	134.0	172.8	206.6	88.6	114.4	139.3

Other		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total Debt		7.3	6.3	7.3	8.2	8.2	5.9	1.6	0.1	0.3	0.0	0.0	6.6	3.1	2.7
Book Value		206.6	95.4	206.6	161.0	185.1	257.2	83.8	96.7	27.3	31.3	21.5	-44.2	-33.7	-28.3

Other		2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		17.0	40.8	95.4	145.1	134.0	172.8	206.6	88.6	114.4	139.3

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-126.6	-183.4	-126.6	-92.9	-82.3	-46.2	-29.1	-20.8	-15.8	-18.6	-11.4	-7.2	-5.7	-2.1
Depreciation & Amortization	0.8	0.9	0.8	0.7	0.6	0.5	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0
Stock-Based Compensation	21.9	12.3	21.9	9.9	11.1	7.1	4.4	3.0	1.1	0.4	0.1	0.0	0.2	0.0
Change Working Capital	15.2	15.0	15.2	7.4	-12.3	8.3	-20.6	-18.8	25.8	-4.2	-0.2	0.8	0.5	0.0
Change In Accounts Receivable	8.2	-3.6	8.2	-2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	4.3	-5.0	4.3	1.1	1.7	0.2	-1.0	1.5	0.2	-1.6	0.4	0.2	0.3	0.0
Change In Inventories	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	-1.1	2.3	-0.5	0.1	4.9	0.1	0.0	-0.1	-0.7	-1.4	-1.7	0.0	0.0	0.1
Cash from Operations	-89.2	0.0	0.0	-75.3	-78.1	-30.2	-44.8	-36.4	10.6	-23.7	-13.2	-6.4	-4.9	-1.8

Cash Flow From Operating Activities	3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Net Income	-5.4	-49.5	-60.1	-52.2	-48.5	-42.3	-40.4	-44.6	-29.0	-27.7
Depreciation & Amortization	0.6	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2
Stock-Based Compensation	0.0	6.2	5.4	-8.6	2.6	0.0	3.0	12.7	0.0	0.0
Change Working Capital	-13.5	-18.8	-4.7	18.8	5.6	0.2	-2.3	16.6	-1.0	3.8
Change In Accounts Receivable	-12.2	-6.6	-1.1	2.8	3.2	-1.1	-1.3	14.4	-2.1	-2.0
Change In Accounts Payable	-1.9	5.0	2.5	-1.4	0.8	-5.9	1.5	6.1	-1.9	0.1
Change In Inventories	-3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	63.6	29.2	4.7	1.5	7.4	2.2	-0.7	0.0	2.3	3.8
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2015	2013
Capital Expenditure	-0.6	-0.9	0.0	-1.2	-0.9	-0.1	-0.2	-1.1	-1.4	-0.1	-0.1	-0.1
Acquisitions	0.0	0.0	0.0	-57.9	-57.9	147.7	-16.8	69.4	0.0	0.0	0.0	0.0
Investments	-189.2	-30.6	-189.2	-98.2	-136.9	-201.2	-49.8	-79.9	0.0	0.0	0.0	0.0
Sales of Investment	105.0	122.5	105.0	140.9	195.7	53.6	66.8	11.5	0.0	0.0	0.0	0.0
Other Investing Activities	0.3	0.0	0.0	57.9	57.9	-147.7	16.8	-69.4	0.0	34.1	0.0	0.0
Cash from Investing	-84.7	0.0	0.0	41.4	57.9	-147.7	16.8	-69.4	-1.4	34.1	-0.1	-0.1

Cash Flow From Investing Activities	3-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Capital Expenditure	0.4	-0.3	0.0	0.0	-0.1	0.0	0.0	0.0	0.0
Acquisitions	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
Investments	21.0	-20.0	38.1	-6.6	0.0	-1.0	-141.5	-18.2	-3.8
Sales of Investment	-22.5	41.7	21.2	15.2	48.9	38.2	15.5	11.6	32.5
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2016	2015	2014	2013
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	-0.2	-0.2	0.0	0.0	-0.2	-0.4
Debt Issued	-0.9	-1.0	-0.9	0.0	2.3	4.3	1.6	0.0	0.4	-6.6	3.5	0.5	3.1
Issuance of Common Stock	150.7	0.0	0.0	56.6	0.0	210.6	11.4	87.9	9.1	0.0	0.0	0.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	150.7	0.0	0.0	1.5	1.6	1.5	0.2	0.2	0.0	33.0	8.7	6.6	6.0
Cash from Financing	150.7	0.0	0.0	58.1	1.6	212.1	11.6	87.9	9.0	33.0	8.7	6.4	5.6

Cash Flow From Financing Activities	3-2026	2-2026	1-2026	4-2025	3-2025	1-2025	4-2024	3-2024	2-2024
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	149.6	143.4	-0.2	0.5	-0.4	-1.1	-0.1	-0.3	-0.3
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Change in Cash		-24.4	99.8	-24.4	25.5	-19.9	34.8	-16.2	-19.0	20.1	9.2	19.2	2.0	1.5	3.6
Closing Cash Balance		31.8	131.6	31.8	56.2	30.7	50.6	15.8	32.0	51.1	31.0	21.8	2.5	9.8	8.2

Cash position		3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Net Change in Cash		-243.5	126.4	-7.3	-35.7	126.4	9.7	0.1	8.7	-34.6	8.3
Closing Cash Balance		0.0	167.9	124.3	132.3	167.9	41.6	31.8	31.8	23.1	57.7

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Free Cash Flow		-89.9	-153.3	-89.7	-76.5	-79.1	-30.3	-45.0	-37.4	9.1	-23.8	-13.2	-6.5	-4.9	-1.9
Real Free Cash Flow		-111.8	-165.6	-111.6	-86.4	-90.2	-37.4	-49.5	-40.4	8.1	-24.2	-13.3	-6.5	-5.1	-2.0

Free Cash Flow		3-2026	2-2026	1-2026	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024
Free Cash Flow		45.5	-32.7	-54.8	-40.0	-32.8	-39.8	-40.2	-15.2	-27.6	-19.8
Real Free Cash Flow		45.5	-38.9	-60.2	-31.4	-35.4	-39.8	-43.3	-28.0	-27.6	-19.8